1. Home
  2. ALLT vs CCCC Comparison

ALLT vs CCCC Comparison

Compare ALLT & CCCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Allot Ltd.

ALLT

Allot Ltd.

N/A

Current Price

$7.89

Market Cap

381.1M

ML Signal

N/A

Logo C4 Therapeutics Inc.

CCCC

C4 Therapeutics Inc.

N/A

Current Price

$3.50

Market Cap

404.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ALLT
CCCC
Founded
1996
2015
Country
Israel
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
381.1M
404.7M
IPO Year
2006
2020

Fundamental Metrics

Financial Performance
Metric
ALLT
CCCC
Price
$7.89
$3.50
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
6
Target Price
$12.40
$12.20
AVG Volume (30 Days)
276.9K
1.9M
Earning Date
05-12-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
16.45
EPS
N/A
N/A
Revenue
N/A
$35,947,000.00
Revenue This Year
$15.84
N/A
Revenue Next Year
$12.09
N/A
P/E Ratio
$469.21
N/A
Revenue Growth
N/A
1.02
52 Week Low
$6.12
$1.69
52 Week High
$11.92
$5.17

Technical Indicators

Market Signals
Indicator
ALLT
CCCC
Relative Strength Index (RSI) 56.50 37.89
Support Level $7.38 $3.40
Resistance Level $8.12 $3.91
Average True Range (ATR) 0.25 0.19
MACD 0.06 -0.06
Stochastic Oscillator 59.82 12.12

Price Performance

Historical Comparison
ALLT
CCCC

About ALLT Allot Ltd.

Allot Ltd is a provider of security and network intelligence solutions for mobile, fixed, and cloud service providers, as well as enterprises. It offers network-based security solutions such as mobile security, DDoS protection, and IoT security, along with network analytics and traffic management. It focuses on expanding its Security-as-a-Service (SECaaS) offerings through the Allot Secure product family, which delivers unified protection for consumers and SMBs across mobile, fixed, and 5G networks. Its Allot Smart solutions enable service providers to analyze and manage network data, optimize performance, reduce costs, and enhance user experience. It has a customer base in Europe, which generates maximum revenue, as well as in Asia and Oceania, the Americas, the Middle East, and Africa.

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patient's lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. The degrader medicines of the company are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT8919, and other discovery products.

Share on Social Networks: